Vildagliptin Amide impurity is a structurally related degradation byproduct of the antidiabetic agent Vildagliptin, characterized by an amide substitution at the terminal pyrrolidin-2-one ring. It retains the core 4-(3-piperidin-1-yl-propyl)phenyl moiety but features an amide linkage replacing the parent compoundβs carboxamide side chain. This impurity arises via hydrolytic cleavage followed by amidation, introducing a secondary amide functional group adjacent to the pyrrolidone core. Its distinct polarity and H-bonding capacity influence chromatographic separation profiles. It serves as a critical HPLC reference standard for quantifying degradation pathways in Vildagliptin formulations.
On RequestC1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C(=O)N
InChI=1S/C17H27N3O3/c18-15(22)13-2-1-3-20(13)14(21)9-19-16-5-11-4-12(6-16)8-17(23,7-11)10-16/h11-13,19,23H,1-10H2,(H2,18,22)/t11?,12?,13-,16?,17?/m0/s1
IUJJPEBUSBVYIP-FBXIQOIYSA-N